Home › Funds › J. Goldman & Co LP › COLL

J. Goldman & Co LP position in COLL

COLLEGIUM PHARMACEUTICAL INC · Health Care

J. Goldman & Co LP reported holding 827,476 shares of COLL (COLLEGIUM PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$18.1M, representing 0.72% of its reported portfolio and ranking #36 among its reported holdings. J. Goldman & Co LP has disclosed COLL holdings in 2 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)827.48K sh
Reported value held$18.06M
Portfolio Weight0.72%
First reportedQ2 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How J. Goldman & Co LP's COLL position evolved

J. Goldman & Co LP first disclosed a stake in COLL in Q2 2025 at 243,448 shares (US$7.2M). The position peaked in Q3 2026 at 827,476 shares, worth US$18.1M. Across 2 filings, J. Goldman & Co LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 827,476 shares valued at US$18.1M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 243.45K $7.20M New
Q3 2026 827.48K $18.06M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COLL and 13F data

COLL (COLLEGIUM PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in COLL — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M), SILVERBACK ASSET MANAGEMENT LLC (US$14.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COLL

All COLL fund holders →

FAQ

How long has J. Goldman & Co LP held COLL?

J. Goldman & Co LP has disclosed COLL holdings in 2 of the last 6 reported quarters, going back to Q2 2025.

What is J. Goldman & Co LP's current position in COLL?

As of Q3 2026, J. Goldman & Co LP holds 827.48K shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $18.06M, representing 0.72% of its reported portfolio and ranking #36.

Has J. Goldman & Co LP been buying or selling COLL?

In the latest 13F filing (Q3 2026), J. Goldman & Co LP newly opened its position in COLL. The position peaked in Q3 2026 at 827.48K shares.

Which other funds hold COLL?

Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., GOLDENTREE ASSET MANAGEMENT LP, SILVERBACK ASSET MANAGEMENT LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.